Insmed Inc. buy Wells Fargo & Company
Start price
19.02.25
/
50%
€78.00
Target price
19.02.26
€102.54
Performance (%)
74.36%
End price
20.02.26
€136.00
Summary
This prediction ended on 20.02.26 with a price of €136.00. With a performance of 74.36% the BUY prediction by Wells_Fargo___Compan was a big success. Wells_Fargo___Compan has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 2.727% | 2.727% | 80.580% |
| iShares Core DAX® | 1,60 % | 5,04 % | 3,87 % |
| iShares Nasdaq 100 | 3,74 % | 14,95 % | 36,14 % |
| iShares Nikkei 225® | 3,74 % | 13,89 % | 43,81 % |
| iShares S&P 500 | 1,82 % | 8,88 % | 25,51 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Wells Fargo & Company from $85.00 to $107.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten